Healthcare AI Exits Pilot Phase, Enters Production Deployment

Executive Summary

• Ventripoint Diagnostics announced a strategic partnership with Nisg_a'a Valley Health Authority to deliver its VMS+ cardiac imaging system to remote and Indigenous communities, establishing a hub‑and‑spoke care model.
• The company appointed David Swetlow as Chief Financial Officer (October 2025) to support execution of a refreshed commercial strategy and a shift toward a Device‑as‑a‑Service subscription model.
• Additional collaborations were disclosed: validation study with Providence Health Care Ventures at St. Paul’s Hospital (implementation early 2026) and renewed capital commitment from European distributor AngioPro.

Key Details

• Partnership with Nisg_a'a Valley Health Authority
• Deploys Ventripoint’s VMS+ system, converting 2‑D ultrasound into 3‑D volumetric models with MRI‑level accuracy.
• Hub‑and‑spoke design: central hub provides specialist interpretation; remote sites capture scans and transmit digitally.

• First remote site is the Nisg_a'a Valley Health Authority; future phases target additional First Nations, Arctic regions, and rural communities worldwide (Amazon, Africa, India).

• CFO Appointment

• David Swetlow named Chief Financial Officer (effective October 2025).

• Brings >15 years senior‑management experience in high‑growth med‑tech firms (Sernova, Ondine, Protox, HealthPricer, QLT).

• Device‑as‑a‑Service (DaaS) Subscription Model

• Shift from traditional equipment sales to recurring‑revenue subscription contracts.

• Management cites shortening of sales cycles and growing qualified leads in Europe & North America.

• Collaboration with Providence Health Care Ventures

• Validation study of VMS+ at St. Paul’s Hospital, Vancouver (late Oct 2025 announcement).
• Goal: assess AI‑enhanced echocardiography’s ability to reduce demand for cardiac MRI scans.

• Implementation slated for early 2026.

• European Distributor Commitment

• AngioPro reaffirmed partnership and injected additional capital to support Ventripoint’s European market expansion.

Notable Quotes

• “Through our collaboration with the Nisg_a'a Nation, we are creating a scalable model of heart care that can extend from the Arctic to the Amazon…,” – Hugh MacNaught, CEO, Ventripoint Diagnostics.
• “Partnering with Ventripoint allows us to explore innovative tools that support more accurate diagnoses, faster treatment decisions, and truly patient‑centred care right here at home,” – Corinne McKay, CEO, Nisg_a'a Valley Health Authority.

The remainder of the release covered broader industry AI trends and updates from other companies (Doximity, Oscar Health, Cognizant, Certara) which are not material to Ventripoint Diagnostics and have been omitted per instructions.